Recurrent/Metastatic Olfactory Neuroblastoma: Evaluating the Efficacy and Safety of Nivolumab

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

Japan

National Cancer Center Hospital East, Kashiwa, Chiba

Jichi Medical University Hospital, Shimotsuke, Tochigi